Idexx Laboratories | IDXX - Cost Of Sales


Idexx Laboratories reported $437.5M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Abbott USD 5.94B 642M Jun/2026
Accuray USD 116.17M 14.63M Dec/2024
Align Technology USD 298.76M 4.74M Jun/2026
AngioDynamics USD 37.29M 786K Sep/2025
Dentsply International USD 405M 48M Jun/2026
Dexcom USD 478.4M 36.8M Jun/2026
Edwards Lifesciences USD 392.4M 29.8M Jun/2026
Fujifilm JPY 550.58B 40.74B Mar/2026
Globus Medical USD 271M 7.41M Jun/2026
Henry Schein USD 2.43B 129M Jun/2026
Idexx Laboratories USD 437.5M 19.42M Jun/2026
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 239.1M 6.4M Jun/2026
Integra LifeSciences USD 188.86M 10.15M Jun/2026
Intuitive Surgical USD 931.9M 8.4M Jun/2026
Neogen USD 117.5M 5.3M Mar/2026
Orthofix International USD 66.63M 6.4M Dec/2025
Phibro Animal Health USD 240.42M 2.58M Dec/2025
ResMed USD 612.93M 61.26M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
Steris USD 808.6M 82.7M Jun/2026
Tandem Diabetes Care USD 109.78M 653K Jun/2026
Teleflex USD 238.62M 2.21M Jun/2026
Thermo Fisher Scientific USD 7.54B 577M Jun/2026
Zoetis USD 704M 32M Jun/2026